|
Ersatz
1. Gartner CE, Barendregt JJ, Hall WD. Multiple genetic tests
for susceptibility to smoking do not outperform simple family history. Addiction. 2009;104:118-26.
2.Gartner CE, Barendregt JJ, Hall WD. Predicting the future prevalence of cigarette smoking in Australia: how low
can we go and by when? Tob Control. 2009;18:183-9.
3. Veerman JL, Beeck EF, van, Barendregt JJ, Mackenbach JP. By how much would limiting TV food advertising reduce childhood obesity? European Journal Public
Health. 2009;19(4):365-9.
4. Barendregt JJ. The effect size in uncertainty analysis. Value in Health. 2010;13(4):388-91.
MetaXL
5. Doi SA, Barendregt JJ, Mozurkewich EL. Meta-analysis Of Heterogenous Clinical Trials: An Empirical Example. Contemporary Clinical Trials. (epub ahead
of print).
6. Doi SA, Thalib L. A quality-effects model for meta-analysis. Epidemiology. 2008 Jan;19(1):94-100.
7. Doi SA, Thalib L. An alternative quality adjustor for the quality effects model for
meta-analysis. Epidemiology. 2009 Mar;20(2):314.
DisMod II
8. Barendregt JJ, Oortmarssen GJ, van, Vos T, Murray CJL. A
generic model for the assessment of disease epidemiology: the computational basis of DisMod II. Population Health Metrics 2003;1(1):4.
9. Barendregt JJ, Ott A. Consistency of epidemiologic estimates. European
Journal of Epidemiology 2005;20(10):827-832.
Risk factor integral
10. Barendregt JJ, Veerman JL. Categorical versus continuous
risk factors, and the calculation of potential impact fractions. Journal of Epidemiology and Community Health. 2010;64:209-12.
Prevent
11. Gunning-Schepers L. The health benefits of prevention: a simulation approach. Health Policy 1989;12(1-2):1-255.
12. Gunning-Schepers LJ, Barendregt
JJ, Van Der Maas PJ. Population interventions reassessed. Lancet 1989;1(8636):479-81.
13. Gunning-Schepers LJ, Barendregt JJ. Timeless epidemiology or history cannot be ignored. J Clin Epidemiol 1992;45(4):365-72.
14. Naidoo B, Thorogood M, McPherson K, Gunning-Schepers LJ. Modelling the effects of increased physical activity on coronary heart disease in England and Wales. J Epidemiol Community Health 1997;51(2):144-50.
15. Gunning-Schepers LJ. Models: instruments for evidence based policy. J Epidemiol Community Health 1999;53(5):263.
16. Mooy JM, Gunning-Schepers LJ. Computer-assisted health impact assessment for
intersectoral health policy. Health Policy 2001;57(3):169-77.
Brønnum-Hansen H. How good is the Prevent model for estimating the health benefits of prevention? J Epidemiol Community Health 1999;53(5):300-5.
17. Brønnum-Hansen H, Juel K. Estimating mortality due to cigarette smoking: two methods, same result. Epidemiology 2000;11(4):422-6.
18. Brønnum-Hansen H. Predicting the effect of prevention of ischaemic heart
disease. Scand J Public Health 2002;30(1):5-11.
Barendregt JJ, Oortmarssen GJ, van, Hout BA, van, Bosch JM, van den, Bonneux L. Coping with multiple morbidity in a life table. Mathematical Population Studies
1998;7(1):29-49.
19. Barendregt JJ, Bonneux L, van der Maas PJ. The health care costs of smoking. N Engl J Med 1997;337(15):1052-7.
20. Barendregt JJ, Bonneux L, Maas PJ, van der. When does nonsmoking save
health care money? The many answers to a simple question. In: Jeanrenaud C, Soguel S, editors. Valuing the cost of smoking. Assessment methods, risk perception and policy options. Boston, Dordrecht, London: Kluwer
Academic Publishers; 1999. p. 75-91.
21. De Vries E, Soerjomataram I, Lemmens VE, Coebergh JW, Barendregt JJ, Oenema A, Moller H, Brenner H, Renehan AG. Lifestyle changes and reduction of colon cancer incidence
in Europe: A scenario study of physical activity promotion and weight reduction. Eur J Cancer. 2010 Sep;46(14):2605-16.
22. Menvielle G, Soerjomataram I, de Vries E, Engholm G, Barendregt JJ, Coebergh JW, Kunst
AE. Scenarios of future lung cancer incidence by educational level: Modelling study in Denmark. Eur J Cancer. 2010 Sep;46(14):2625-32.
23. Soerjomataram I, de Vries E, Engholm G, Paludan-Muller G, Bronnum-Hansen
H, Storm HH, Barendregt JJ. Impact of a smoking and alcohol intervention programme on lung and breast cancer incidence in Denmark: An example of dynamic modelling with Prevent. Eur J Cancer. 2010 Sep;46(14):2617-24.
24. Soerjomataram I, Oomen D, Lemmens V, Oenema A, Benetou V, Trichopoulou A, Coebergh JW, Barendregt JJ, de Vries E. Increased consumption of fruit and vegetables and future cancer incidence in selected
European countries. Eur J Cancer. 2010 Sep;46(14):2563-80.
|
|
